Essenvia Raises $4M Pre-A Round Led By Wavemaker And Bgv To Help Medtech Teams Supercharge Regulatory Submissions
Essenvia Raises $4M Pre-A Round Led By Wavemaker And Bgv To Help Medtech Teams Supercharge Regulatory Submissions
05/02/23, 4:05 PM
Location
woodland hillsMoney raised
$4 million
Industry
information technology
Round Type
seed
Investors
Pasadena Angels, Rebright Partners, First Rays, Wavemaker360, Benhamou Global Ventures
Essenvia, the pioneer in regulatory submission management for the MedTech industry, today announced it closed $4M in Pre Series A financing led by Benhamou Global Ventures and Wavemaker360 with participation from existing investors First Rays, Rebright partners, as well as Pasadena Angels. The company announced the appointment of Wavemaker360 partner Kwame Ulmer and BGV Partner Yashwanth Hemaraj to Essenvia's board of directors.
Company Info
Location
21201 kittridge st. #3301
woodland hills, california, united states
Additional Info
Essenvia is an online software to streamline pre and post market workflow for medical device companies by streamlining plans or activities to market, improving cross-functional collaboration and automating steps to manage initial and subsequent device modifications.
It takes 2-5 years for new or improved medical devices to reach market and medical device companies manage a complex, specialized workflow prone with errors.
Research shows regulatory submissions have grown in complexity and size, with a consistent 30% rejected at initial review and 64% sent back for additional information costing the industry billions of dollars each year.
Our program is designed to help drastically reduce submission errors, streamline data and information gathering, save time, and help you submit a close to rejection proof as possible 510k submission.